Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
eWeek5d
Sam Altman’s AI Briefing: Super-Agents To Revolutionize Software, Finance, and More
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
NextBigFuture6d
Sam Altman Says AI Takeoff in Small Number of Years Not Months or a Decade
Sam Altman, the CEO of OpenAI, now says he is more confident of a fast AI takeoff. A fast AI takeoff is more possible than he ...
Sam Altman says the kid he’s expecting soon will never be smarter than AI, but thinks this ability will be valuable
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...